Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

AI and Gene Therapy: The Next Frontier in Life Science Innovation

Uncover the emerging role of AI in the revolutionary field of gene therapy and how it is paving the way for groundbreaking advancements.

Featured

Bioinformatics

Form Bio and Google Team Up To Streamline Multiomics and Accelerate Precision Medicine

Discover how Form Bio and Google Cloud’s Multiomics Suite will empower life scientists to accelerate research, development, and pre-clinical studies in personalized medicine and gene therapies.

Featured

Vector Design

Leveraging AI Models To Improve Safety of Gene Therapy

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Featured

Biomanufacturing

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Featured

Artificial Intelligence

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

Featured

Vector Design

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.

Perspectives on Optimizing DNA Based Large Language Models

Featured

Artificial Intelligence

Perspectives on Optimizing DNA Based Large Language Models

Austin Day, PhD

July 26, 2023

Despite having access to diverse data and a vast number of parameters, new DNA large language models often struggle to learn hard tasks. Our AI expert, Austin, shares his insights on the possible reasons why.

The Gene Therapy Developer's Introduction to AI and Computational Life Sciences

Featured

Artificial Intelligence

The Gene Therapy Developer's Introduction to AI and Computational Life Sciences

Jill Roughan, PhD

May 29, 2023

Discover the progression of AI from inception to present-day, and how it powers the efficient analysis of big data, revolutionizes gene therapy development, and advances biomanufacturing.

Featured

Biomanufacturing

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Claire Aldridge, PhD

May 15, 2023

Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Featured

Vector Design

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

April 18, 2023

Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.

Featured

Biomanufacturing

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Jill Roughan, PhD

April 4, 2023

Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Featured

Artificial Intelligence

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

March 22, 2023

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Featured

Vector Design

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Nick Ketz, PhD

March 8, 2023

Transformer based architectures are uniquely efficient and powerful when used to process structured data. Read this blog to learn how they can be customized, adapted and applied to AAV construct optimization.

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Featured

Vector Design

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Jill Roughan, PhD

February 23, 2023

In this article, we take a look at the role of viral vectors in gene therapy clinical trials, including current challenges and leveraging artificial intelligence to advance the field.

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Featured

Bioinformatics

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Jill Roughan, PhD

February 14, 2023

Want to know more about the foundational types and common tools to use for RNA-Seq data visualization in gene therapy development? Read this blog to find out.

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Featured

Bioinformatics

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Jill Roughan, PhD

February 7, 2023

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Featured

Artificial Intelligence

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Jill Roughan, PhD

February 1, 2023

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Featured

Biomanufacturing

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

January 31, 2023

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

Form Bio Resources

Artificial Intelligence

How To Characterize Your AAV Gene Therapy Construct Early On To Enhance Manufacturing Product Quality

Jill Roughan, PhD

November 20, 2023

Learn the essential steps for characterizing your gene therapy product with bioreactor simulator runs in your pre-clinical development stage.

Artificial Intelligence

Solving Gene Therapy Product Development Challenges Through Analytical Standardization

Jill Roughan, PhD

October 17, 2023

Learn how to overcome product quality challenges when moving from pre-clinical to commercialization of AAV gene therapy.

Artificial Intelligence

How Can You Integrate AI into Life Science Programs, And When Should You Do It?

Claire Aldridge, PhD

November 7, 2023

Explore the boundless potential at the intersection of life sciences and AI. Discover actionable insights to embark on this journey leveraging cutting-edge technology.

Board of Directors

Johnnn

Doe

,

Ph.D.

CEO

John

Doe

,

Ph.D.

CEO

Johnnn

Doe

,

Ph.D.

CEO

Johnn

Doe

,

Ph.D.

CEO

Form Bio Resources

Artificial Intelligence

Form Bio Blog

AI and Gene Therapy: The Next Frontier in Life Science Innovation

Form Bio and Google Team Up To Streamline Multiomics and Accelerate Precision Medicine

Leveraging AI Models To Improve Safety of Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Perspectives on Optimizing DNA Based Large Language Models

The Gene Therapy Developer's Introduction to AI and Computational Life Sciences

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Maximizing Therapeutic Efficacy Through Codon Substitution Design

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Form Bio Resources

How To Characterize Your AAV Gene Therapy Construct Early On To Enhance Manufacturing Product Quality

Solving Gene Therapy Product Development Challenges Through Analytical Standardization

How Can You Integrate AI into Life Science Programs, And When Should You Do It?

Board of Directors

Johnnn

Doe

,

Ph.D.

John

Doe

,

Ph.D.

Johnnn

Doe

,

Ph.D.

Johnn

Doe

,

Ph.D.

Form your future breakthroughs

See how Form can empower you

Get informed

Form Bio Resources

How Can You Integrate AI into Life Science Programs, And When Should You Do It?

Solving Gene Therapy Product Development Challenges Through Analytical Standardization

How To Characterize Your AAV Gene Therapy Construct Early On To Enhance Manufacturing Product Quality